[go: up one dir, main page]

EP4353091A3 - Formulation aérosolisable - Google Patents

Formulation aérosolisable Download PDF

Info

Publication number
EP4353091A3
EP4353091A3 EP24152849.6A EP24152849A EP4353091A3 EP 4353091 A3 EP4353091 A3 EP 4353091A3 EP 24152849 A EP24152849 A EP 24152849A EP 4353091 A3 EP4353091 A3 EP 4353091A3
Authority
EP
European Patent Office
Prior art keywords
aerosolisable formulation
aerosolisable
formulation
nicotine
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP24152849.6A
Other languages
German (de)
English (en)
Other versions
EP4353091A2 (fr
EP4353091B1 (fr
Inventor
Ross CABOT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicoventures Trading Ltd
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of EP4353091A2 publication Critical patent/EP4353091A2/fr
Publication of EP4353091A3 publication Critical patent/EP4353091A3/fr
Application granted granted Critical
Publication of EP4353091B1 publication Critical patent/EP4353091B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241—Extraction of specific substances
    • A24B15/243—Nicotine
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/05—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10—Devices using liquid inhalable precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
EP24152849.6A 2018-11-01 2019-10-31 Formulation aérosolisable Active EP4353091B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1817865.7A GB201817865D0 (en) 2018-11-01 2018-11-01 Aerosolisable formulation
EP19798365.3A EP3873245B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable
PCT/GB2019/053092 WO2020089637A1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP19798365.3A Division EP3873245B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable
EP19798365.3A Division-Into EP3873245B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable

Publications (3)

Publication Number Publication Date
EP4353091A2 EP4353091A2 (fr) 2024-04-17
EP4353091A3 true EP4353091A3 (fr) 2024-07-10
EP4353091B1 EP4353091B1 (fr) 2025-08-06

Family

ID=64655353

Family Applications (2)

Application Number Title Priority Date Filing Date
EP24152849.6A Active EP4353091B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable
EP19798365.3A Active EP3873245B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP19798365.3A Active EP3873245B1 (fr) 2018-11-01 2019-10-31 Formulation aérosolisable

Country Status (16)

Country Link
US (1) US20210386110A1 (fr)
EP (2) EP4353091B1 (fr)
JP (1) JP7703445B2 (fr)
KR (1) KR102684717B1 (fr)
CN (1) CN113015444A (fr)
AU (1) AU2019371079B2 (fr)
BR (1) BR112021008556A2 (fr)
CA (1) CA3118051A1 (fr)
ES (1) ES2984536T3 (fr)
GB (1) GB201817865D0 (fr)
IL (1) IL282523A (fr)
MX (1) MX2021005123A (fr)
MY (1) MY204015A (fr)
PL (2) PL3873245T3 (fr)
UA (1) UA128040C2 (fr)
WO (1) WO2020089637A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB202013489D0 (en) 2020-08-27 2020-10-14 Nicoventures Holdings Ltd Consumable
US11771132B2 (en) 2020-08-27 2023-10-03 Rai Strategic Holdings, Inc. Atomization nozzle for aerosol delivery device
US11771136B2 (en) 2020-09-28 2023-10-03 Rai Strategic Holdings, Inc. Aerosol delivery device
IT202100022172A1 (it) * 2021-08-23 2023-02-23 Natural Acad S R L Composizione liquida medicale per somministrazione aerea
KR20240028723A (ko) * 2022-08-25 2024-03-05 주식회사 케이티앤지 산을 포함하는 흡연물품

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034068A1 (en) * 2002-06-03 2004-02-19 Woodcock Washburn Llp New formulation and use thereof
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
WO2019086858A1 (fr) * 2017-11-01 2019-05-09 British American Tobacco (Investments) Limited Formulation aérosolisable
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0462094U (fr) * 1990-10-09 1992-05-27
AU717600B2 (en) * 1993-07-26 2000-03-30 Mcneil Ab Improved nicotine lozenge and therapeutic method for smoking cessation
US20080138399A1 (en) * 1999-07-16 2008-06-12 Aradigm Corporation Dual release nicotine formulations, and systems and methods for their use
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
WO2004060351A2 (fr) * 2002-12-31 2004-07-22 Nektar Therapeutics Formulation pharmaceutique ayant un agent actif insoluble
SE0300520D0 (sv) * 2003-02-28 2003-02-28 Pharmacia Ab A container comprising nicotine and the use and manufacture thereof
US20070267033A1 (en) * 2006-02-09 2007-11-22 Philip Morris Usa Inc. Gamma cyclodextrin flavoring-release additives
CN101583354A (zh) * 2006-12-01 2009-11-18 阿拉迪姆公司 用于终止烟草使用的系统
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
GB0918129D0 (en) * 2009-10-16 2009-12-02 British American Tobacco Co Control of puff profile
US9333229B2 (en) * 2013-10-16 2016-05-10 William Bjorncrantz Winterized crude cannabis extracts and methods of preparation and use
TWI664918B (zh) * 2014-05-21 2019-07-11 瑞士商菲利浦莫里斯製品股份有限公司 可感應加熱的菸草產品
GB2528673B (en) * 2014-07-25 2020-07-01 Nicoventures Holdings Ltd Aerosol provision system
GB201413835D0 (en) * 2014-08-05 2014-09-17 Nicoventures Holdings Ltd Electronic vapour provision system
GB2535427A (en) 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20160198759A1 (en) 2015-01-13 2016-07-14 Zip Llc E-cigarette or vaping fluid
US20170325494A1 (en) * 2016-05-16 2017-11-16 Lunatech, Llc Liquid composition containing nicotine from non-tobacco source for use with electronic vaporizing devices
US12114688B2 (en) * 2017-10-24 2024-10-15 Rai Strategic Holdings, Inc. Method for formulating aerosol precursor for aerosol delivery device
US20190328040A1 (en) * 2018-04-30 2019-10-31 Zayd Abdulfuhah Turbi Systems and Methods for Buffered Aerosol Drug Delivery
GB201817859D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040034068A1 (en) * 2002-06-03 2004-02-19 Woodcock Washburn Llp New formulation and use thereof
DE102015117811A1 (de) * 2015-10-20 2017-04-20 Chv Pharma Gmbh & Co. Kg Inhalator sowie wirkstoffhaltige Zubereitung für einen Inhalator
WO2019086858A1 (fr) * 2017-11-01 2019-05-09 British American Tobacco (Investments) Limited Formulation aérosolisable
EP3574902A1 (fr) * 2018-06-01 2019-12-04 Yatzz Limited Formulation de nicotine et mode d'administration

Also Published As

Publication number Publication date
WO2020089637A1 (fr) 2020-05-07
ES2984536T3 (es) 2024-10-29
MY204015A (en) 2024-07-31
AU2019371079A1 (en) 2021-05-27
JP7703445B2 (ja) 2025-07-07
BR112021008556A2 (pt) 2021-08-03
PL3873245T3 (pl) 2024-07-29
US20210386110A1 (en) 2021-12-16
EP3873245B1 (fr) 2024-02-28
IL282523A (en) 2021-06-30
EP3873245A1 (fr) 2021-09-08
EP4353091A2 (fr) 2024-04-17
KR20210075107A (ko) 2021-06-22
PL4353091T3 (pl) 2025-11-24
JP2022506094A (ja) 2022-01-17
GB201817865D0 (en) 2018-12-19
UA128040C2 (uk) 2024-03-20
CA3118051A1 (fr) 2020-05-07
NZ775331A (en) 2024-09-27
KR102684717B1 (ko) 2024-07-11
CN113015444A (zh) 2021-06-22
AU2019371079B2 (en) 2022-07-14
MX2021005123A (es) 2021-06-15
EP4353091B1 (fr) 2025-08-06

Similar Documents

Publication Publication Date Title
EP4353091A3 (fr) Formulation aérosolisable
EP3758671A4 (fr) 1,2-alcanediols naturels, compositions comportant des 1,2-alcanediols naturels et leurs procédés de préparation
WO2019079743A8 (fr) Compositions pour l'hémolyse et la régulation de la coagulation et la stabilisation de vésicules extracellulaires
MX2021005117A (es) Formulacion aerosolizable.
WO2003095080A3 (fr) Appareil et procede permettant de creer un produit pret a l'emploi a partir d'une forme concentree
EP3981251A3 (fr) Combinaisons fongicides
MX2021007626A (es) Formulacion de nicotina liquida de baja viscosidad.
MX2019004341A (es) Metodos y sistemas para mejorar la estabilidad de la formulacion prevapor de un dispositivo de vapeo electronico.
MY201970A (en) Aerosolisable formulation
WO2020171727A3 (fr) Compositions mucoadhésives et leurs utilisations
MY206012A (en) Aerosolisable formulation
MY193486A (en) Novel 5 ' -inosinic acid dehydrogenase and method preparing 5'-inosinic acid using the same
ZA202006535B (en) Pharmaceutical composition comprising salbutamol
MY203193A (en) Aerosolisable formulation
MY188643A (en) Cosmetic
EP4245337A3 (fr) Gel pouvant former un aérosol
WO2019210216A3 (fr) Édition de gènes à base de talen et de crispr/cas pour la tyrosine kinase de bruton
MY200338A (en) Flavoured vaporisable formulation
EP4360473A3 (fr) Film de génération d'aérosol
ZA202100040B (en) Aerosolisable formulation
AU2017370226A1 (en) Pharmaceutical composition containing insulin-like growth factor-2 and use thereof
EP4364568A3 (fr) Mélange fongicide
WO2020046059A3 (fr) Procédé d'inhibition de la génération de poussière, composition de stabilisateur de sol et dispositif de pulvérisation le comprenant
WO2019195355A9 (fr) Comprimé ou composition à base d'éthanolamine n-acyle et de cannabinoïde
WO2018144870A8 (fr) Compositions et méthodes permettant d'inhiber l'inhibiteur reticulon 4

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 3873245

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A24B 15/167 20200101AFI20240531BHEP

P01 Opt-out of the competence of the unified patent court (upc) registered

Free format text: CASE NUMBER: APP_62485/2024

Effective date: 20241122

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20241227

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20250303

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 3873245

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019073968

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20250806